| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pharmacokinetic model for L-carnitine in patients receiving haemodialysis
|
Fornasini, Gianfranco
|
|
2007
|
64 |
3 |
p. 335-345
|
article
|
| 2 |
Authors' response: Homeopathy is safe and does not lack positive evidence in clinical trials/Scottish GPs use of Homeopathy
|
Ross, Sarah
|
|
2007
|
64 |
3 |
p. 398-399
|
article
|
| 3 |
Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards
|
Goldstein, Lee H.
|
|
2007
|
64 |
3 |
p. 373-380
|
article
|
| 4 |
CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment
|
Mehlotra, Rajeev K.
|
|
2007
|
64 |
3 |
p. 391-395
|
article
|
| 5 |
Development of oral anticoagulants
|
Ma, Qing
|
|
2007
|
64 |
3 |
p. 263-265
|
article
|
| 6 |
Editors' Report for 2006
|
|
|
2007
|
64 |
3 |
p. 253-254
|
article
|
| 7 |
Effect of renal impairment on the pharmacokinetics of exenatide
|
Linnebjerg, Helle
|
|
2007
|
64 |
3 |
p. 317-327
|
article
|
| 8 |
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole
|
Sostek, Mark B.
|
|
2007
|
64 |
3 |
p. 386-390
|
article
|
| 9 |
Erratum
|
|
|
2007
|
64 |
3 |
p. 401
|
article
|
| 10 |
Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience
|
Tobaiqy, Mansour
|
|
2007
|
64 |
3 |
p. 363-372
|
article
|
| 11 |
Heart Rate Slowing by If Current Inhibition
|
|
|
2007
|
64 |
3 |
p. 400
|
article
|
| 12 |
Homeopathy is safe and does not lack positive evidence in clinical trials
|
Mathie, Robert T.
|
|
2007
|
64 |
3 |
p. 396-397
|
article
|
| 13 |
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients
|
Solas, Caroline
|
|
2007
|
64 |
3 |
p. 353-362
|
article
|
| 14 |
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
|
Esposito-Festen, J. E.
|
|
2007
|
64 |
3 |
p. 328-334
|
article
|
| 15 |
Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath®) in patients with chronic lymphocytic leukaemia and its link to treatment response
|
Mould, D. R.
|
|
2007
|
64 |
3 |
p. 278-291
|
article
|
| 16 |
Primary care prescribing patterns in Ireland after the publication of large hypertension trials
|
Kabir, Zubair
|
|
2007
|
64 |
3 |
p. 381-385
|
article
|
| 17 |
Randomized exposure-controlled trials; impact of randomization and analysis strategies
|
Karlsson, Kristin E.
|
|
2007
|
64 |
3 |
p. 266-277
|
article
|
| 18 |
Scottish GPs use of homeopathy
|
Leckridge, Robert
|
|
2007
|
64 |
3 |
p. 397-398
|
article
|
| 19 |
Should we tolerate tolerability as an objective in early drug development?
|
Cohen, A.
|
|
2007
|
64 |
3 |
p. 249-252
|
article
|
| 20 |
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women
|
Civelli, Maurizio
|
|
2007
|
64 |
3 |
p. 304-316
|
article
|
| 21 |
SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients
|
Zhang, Wei
|
|
2007
|
64 |
3 |
p. 346-352
|
article
|
| 22 |
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
|
Stangier, Joachim
|
|
2007
|
64 |
3 |
p. 292-303
|
article
|
| 23 |
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies
|
Bonovas, Stefanos
|
|
2007
|
64 |
3 |
p. 255-262
|
article
|
Journal description